Fundraising Fox

Biotech Investors & VC Firms in Japan

120 firms in this list, with a median first check of $1M. 18 of them lead rounds. Generated from verified public data and updated continuously.

Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
33 people
Gobi Partners
Hong KongPre-Seed–Late Stage$709K – $37M
74 people
IMM Investment Japan
SeoulSeed–Late Stage
21 people
HongShan Capital Group
Hong KongPre-Seed–Late Stage$100K – $50M
46 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
30 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
12 people
Eight Roads Ventures
MumbaiSeed–Late Stage$5M – $30M
20 people
Taiwania Capital
TaipeiSeed–Growth$3M – $85M
46 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
42 people
Vertex Ventures China
SingaporePre-Seed–Late Stage$2M – $85M
8 people
GoAhead Ventures
Menlo ParkPre-Seed–Series A$500K – $1M
5 people
ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
Fortune Venture Capital
ShenzhenSeed–Late Stage$425K – $73M
11 people
Samsung Ventures
SeoulSeed–Late Stage
26 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
30 people
Mitsui Global Investment
Menlo ParkPre-Seed–Late Stage$500K – $10M
12 people
Pangaea Ventures Us Inc.
VancouverSeed–Late Stage$500K – $1.5M
13 people
Mosaic Venture Lab
Taipei CitySeed$1.5M – $2M
15 people
Remiges Ventures, Inc.
SeattlePre-Seed–Seed
22 people
Astellas Venture Management LLC
South San FranciscoSeed–Growth$200K – $5M
10 people
Quantonation
ParisPre-Seed–Series B
13 people
SAV (Scale Asia Ventures)
Palo AltoSeed–Series B
12 people
MedTech Actuator
Seed–Series B
LYFE Capital
Menlo ParkSeed–Late Stage
16 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.